Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol., 10 July 2020
Sec. Gastrointestinal and Hepatic Pharmacology

Toxicological and Pharmacological Activities of Leptohyptis macrostachys (Benth.) Harley and J.F.B.Pastore (Lamiaceae) on Intestinal Smooth Muscle

Iara Leo Luna de SouzaIara Leão Luna de Souza1Maria Allynne de VasconcelosMaria Allynne de Vasconcelos2Anne Dayse Soares da SilvaAnne Dayse Soares da Silva3Polyana Cristina Barros SilvaPolyana Cristina Barros Silva2Carlos Arthur Gouveia VelosoCarlos Arthur Gouveia Veloso4Diego Igor Alves Fernandes de AraújoDiego Igor Alves Fernandes de Araújo4Vicente Carlos de Oliveira CostaVicente Carlos de Oliveira Costa4Hilzeth Luna Freire PessaHilzeth Luna Freire Pessôa5Josean Fechine Tavares,Josean Fechine Tavares4,6Marcelo Sobral da Silva,Marcelo Sobral da Silva4,6Bagnlia Araújo da Silva,Bagnólia Araújo da Silva4,6Fabiana de Andrade Cavalcante,*Fabiana de Andrade Cavalcante4,7*
  • 1Departamento de Ciências Biológicas e Saúde, Universidade Estadual de Roraima, Boa Vista, Brazil
  • 2Instituto de Ciências Biológicas e da Saúde, Universidade Federal de Alagoas, Maceió, Brazil
  • 3Programa de Pós-graduação em Química e Biotecnologia, Instituto de Química, Universidade Federal de Alagoas, Maceió, Brazil
  • 4Instituto de Pesquisa em Fármacos e Medicamentos, Universidade Federal da Paraíba, João Pessoa, Brazil
  • 5Departamento de Biologia Molecular, Centro de Ciências Exatas e da Natureza, Universidade Federal da Paraíba, João Pessoa, Brazil
  • 6Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Brazil
  • 7Departamento de Fisiologia e Patologia, Centro de Ciências da Saúde, Universidade Federal da Paraíba, João Pessoa, Brazil

Leptohyptis macrostachys, previously known as Hyptis macrostachys Benth., is used in folk medicine to relieve the symptoms of asthma, cough, and bronchitis. Recently, we showed that the ethanol extract obtained from Leptohyptis macrostachys has selective spasmolytic activity on guinea pig ileum. Therefore, the aim of this study was to characterize the spasmolytic mechanism of this extract, investigated whether it presents toxicological and antidiarrheal activities. Therefore, the crude ethanolic extract of Leptohyptis macrostachys was analyzed by high-performance liquid chromatographic-diode array detection (HPLC–DAD). The spasmolytic effect was evaluated on guinea pig ileum, toxicological activity using rats and antidiarrheal activity using male and female mice. In HPLC-DAD analysis, Rosmarinic acid (5.44%) was the most abundant phenolic compound, being considered as a chemical marker. The spasmolytic potency of the extract on histamine-induced contraction was reduced in the presence of 1 mM TEA+, a selective big–conductance K+ channels blocker (BKCa). The extract produces a dose–dependent antidiarrheal activity, inhibiting equipotently defecation frequency and liquid stool formation. In addition, the extract has inhibited in a dose–dependent manner both castor oil–induced intestinal transit and intestinal fluid content. Thus, the spasmolytic activity of the extract involves positive modulation of BKCa and its antidiarrheal activity is related to inhibition of intestinal motility and secretion.

Introduction

Lamiaceae, also called as the mint family, has a worldwide distribution and includes around 295 genus and 7,780 species (Stevens, 2001). It has species with high economic importance used as cosmetics, condiments, medicines, among others (Sousa and Couri, 2013). Hyptis, a highlighter genus of this family, is composed by 400 species with broad distribution in America, Oceania, and Africa (Raja, 2012). This genus has different species that have therapeutic potential such as antifungal (Rocha et al., 2019), antinociceptive, anti-inflammatory (Anjos et al., 2017; Figueiredo et al., 2019), antiedematogenic (Barbosa et al., 2017), antibacterial (Andrade et al., 2017), among others. In addition, several Hyptis species have shown spasmolytic and antidiarrheal effects, such as H. fruticosa, H. pectinata, H. martiusii (Agra et al., 2008), H. suavelons (Agra et al., 2008; Attah et al., 2012; Shaikat et al., 2012), H. capitata (Almtorp et al., 1991), and H. macrostachys (Souza et al., 2013; Costa et al., 2014).

Leptohyptis macrostachys (Benth.) Harley and J.F.B.Pastore, previously known as Hyptis macrostachys Benth., it is a species popularly known in Brazil as “alfavaca-brava” and “hortelã–do–mato,” is used in folk medicine to relieve the symptoms of asthma, cough, and bronchitis (Agra et al., 2008). Recently, we developed a pharmacological screening with the crude ethanolic extract obtained from the aerial parts of L. macrostachys (LM-EtOHAP) in different smooth muscles (rat aorta, rat uterus, and guinea pig trachea and ileum) and this preliminary study showed a selective spasmolytic effect of the extract on guinea pig ileum (Souza et al., 2013).

Currently, diarrhea treatment involves the use of spasmolytic, anti-motility, anti–secretory, anti–fungi and anti-bacteria agents, and/or oral rehydration therapy. Despite this, the therapy varies in potency, availability of systemic action, availability of the central nervous system, in addition to addictive potential and the potential side effects include constipation, cramps, nausea, and colon ischemia (Schiller, 2017). This disease can be related to viral, bacterial, and fungi infection, food poisoning, among other conditions. Since uncontrolled diarrhea results in severe dehydration and death, the search for potent drugs with antidiarrheal properties is growing, in order to reduce the pattern of adverse effects (Otimenyin and Uzochukwu, 2010).

Therefore, based on the fact that pharmacologic diarrhea therapy can include spasmolytic agents, we decided to better characterize the spasmolytic action mechanism of LM-EtOHAP on guinea pig ileum and investigated whether this extract presents toxicological and antidiarrheal activities.

Material and Methods

Plant Material

L. macrostachys was collected in Pico do Jabre, Maturéia municipality, Paraíba, Brazil, in March 2009 and identified by Maria de Fátima Agra (PhD) of the Programa de Pós–graduação em Produtos Naturais e Sintéticos Bioativos (PPgPNSB) of Centro de Ciências da Saúde (CCS) of Universidade Federal da Paraíba (UFPB). The voucher specimen is deposited in the Herbarium Prof. Lauro Pires Xavier/UFPB, under the identification code “Agra 6947.”

Extraction

Plant material was dried in a stove with circulating air (40°C) and chopped by a mechanical mill. The fine powdered from aerial parts (3.0 kg) was macerated with 95% ethanol (5 L) during 72 h. The extraction solution was concentrated under vacuum in a rotaevaporator to give 200 g of ethanol extract of the aerial parts of L. macrostachys.

High-Performance Liquid Chromatography Analysis

Analytical separation was performed using an HPLC‐DAD system consisting of a Prominence Shimadzu LC-20AT quaternary pump, a degasser DGU 20 A-Sr, an auto-injector SIL - 20 A, an oven CTO - 20 A, a photodiode array detector SPD‐M20 A with a CBM-20 A interface, and a Kromasil® 100 column – C-18 (250 × 4.6 mm - 5 μm) protected by a pre-column Security Guard Gemini® C-18. HPLC data acquisition was performed by LC Solution software. The optimized analytical separations of rosmarinic acid were carried out using a mobile phase that consisted of 0.1% formic acid in water (solvent A) and methanol (solvent B) with the following method: 1–12 min: 0 to 40% of B; 12–15 min: 40 to 50% of B; 15–22 min: 50% of B; 22–24 min: 50 to 40% of B; 24–30 min: 40% of B. A flow rate of 1.0 ml/min at 30°C and an injection volume of 20 μl were employed. The UV spectra were recorded at 329 nm. The rosmarinic acid standard (>99%) was purchased by Sigma-Aldrich®. The samples were filtered through a 0.45-μm nylon membrane (Tedia Brasil®). Seven solutions of different concentrations of rosmarinic acid (10 to 70 μg/ml) were injected in triplicate, and the regression equation and the linearity factor were determined. The LOD was calculated based on a signal-to-noise ratio (S/N) of three, while the LOQ was determined at an S/N of ten. The noise level was measured during the analysis of one of the samples and involved a portion of the chromatogram that was separated from the region containing the rosmarinic acid peak.

Animals

On experimental protocols were used guinea pigs (Cavia porcellus) weighting 350–500 g of both sexes, male Wistar rats (Rattus norvegicus) weighting 200–300 g, and Swiss mice (Mus muscullus) weighing 25–35 g of both sexes. The mice and male rats were obtained from the Central Bioterium of Universidade Federal de Alagoas (UFAL) and guinea pigs were obtained from the Bioterium “Professor Thomas George” of UFPB. Previously, the animals were maintained in a 12-h light-dark cycle under controlled temperature (21 ± 1°C) and with free access to food and water. The experimental procedures were approved by the Ethics Committee in Research (CEP) of UFAL, certificate no. 006775/2011-09 and the Ethics Committee on Animal Use (CEPA/UFPB), certificate no. 0506/05.

Chemicals

Magnesium sulphate (MgSO4), potassium chloride (KCl), calcium chloride (CaCl2), and sodium chloride (NaCl) were purchased from Vetec Química Fina Ltda. (Brazil). Glucose (C6H12O6) and sodium bicarbonate (NaHCO3) were purchased from Dinâmica (Brazil). Sodium dihydrogen phosphate (NaH2PO4) was purchased from Nuclear (Brazil). Histamine, atropine, Cremophor®, Triton-X 100®, apamin, cesium chloride (CsCl), tetraethylammonium chloride (TEA+), 4–aminopyridine (4–AP), and glibenclamide were obtained from Sigma–Aldrich (Brazil). Carboxymethylcellulose and castor oil were obtained from Fórmula (Brazil). Loperamide was obtained from Janssen Cilag Farmacêutica Ltda. (Brazil) and the activated charcoal was obtained from Proquímios (Brazil).

All substances were diluted in distilled water and the extract was solubilized in Cremophor®, dissolved in distilled water as needed for each experimental protocol. The final concentration of Cremophor® did not show any interference in the in vivo experiments, according to data from previous experiments.

Participation of K+ Channel on the Spasmolytic Activity of LM-EtOHAP on Guinea Pig Ileum

Guinea pigs (n = 5) were fasted for 18 h and euthanized by cervical dislocation followed by the sectioning of the cervical vessels and the ileum was removed, cleaned of adhering fat and connective tissues. Segments of approximately 2 to 3 cm in length were suspended in organ bath (5 ml) and stabilized for 30 min in modified Krebs solution (mM): NaCl (117.0), KCl (4.7), MgSO4 (1.3), NaH2PO4 (1.2), CaCl2 (2.5), NaHCO3 (25.0), and glucose (11.0) at 37°C and bubbled with a carbogen mixture (95% O2 and 5% CO2) in a resting tension of 1 g (Daniel et al., 2001).

After stabilization, a contraction was evoked with histamine (10-6 M) in both absence (control) and presence of CsCl (5 mM), a non-selective K+ channels blocker (Cecchi et al., 1987); glibenclamide (10-5 M), a selective ATP sensitive K+ channels blocker (KATP) (Sun and Benishin, 1994); 4–aminopyridine (0.3 mM), a selective voltage activated K+ channels blocker (KV) (Robertson and Nelson, 1994); apamin (100 nM), a selective small–conductance K+ channels blocker (SKCa) (Ishii et al., 1997); and TEA+ (1 mM), a selective big–conductance K+ channels blocker (BKCa) (Knot et al., 1996) in independent experiments, which were added to the organ baths 20 min before the histamine–induced contraction. During the sustained phase of the contraction, LM-EtOHAP (0.1–729 μg/ml) was cumulatively added to obtain a relaxation curve.

The relaxation induced by LM-EtOHAP was expressed as the reverse percentage of the initial contraction induced with the agonist. LM-EtOHAP relaxant potency was measured by the molar concentration of a substance that produces half of its maximum effect (EC50) and the maximal relaxant response by the maximum effect (Emax).

Toxicological Evaluation

Investigation of the Hemolytic Effect of LM-EtOHAP in Rat Erythrocytes

After 12 h of fasting period, a blood sample of rats (250, 500, and 750 µg/ml, n = 3) was collected via cardiac puncture, mixed with NaCl 0.9% and CaCl2 10 mM and centrifuged at 2,500 rpm for 5 min (twice) to obtain the erythrocytes. Triton X-100® 1% (100 µl, positive control) or LM–EtOHAP (different concentrations) was added to erythrocytes suspension. The negative control was an erythrocytes suspension plus NaCl 0.9% and CaCl2 10 mM. Hemolysis was quantitated by spectrophotometry at 540 nm and expressed as percentage (Rangel et al., 1997).

Evaluation of the Acute Toxicity

After 12 h of fasting period, male (n = 6) and female (n = 6) mice were treated with NaCl 0.9% (10 ml/kg) plus Cremophor® (negative control) or LM-EtOHAP (2,500 or 5,000 mg/kg) orally (p.o.) or (1,000 or 2,000 mg/kg) intraperitoneally (i.p.). General signs and symptoms of toxicity, such as contortions, aggression, sedation, and others were recorded by 4 h. The assessment of these types of behaviors was based on Almeida et al. (1999). The animals were also evaluated up to 24 h and 14 days in order to monitoring lethality and determine the lethal dose of extract to 50% of treated animals (LD50). Based on this test, doses for pharmacological studies were determined (Almeida et al., 1999).

Evaluation of Antidiarrheal Activity of LM-EtOHAP in Mice

Effect of LM-EtOHAP on Castor Oil-Induced Diarrhea

After 12 h of fasting period, male and female mice were divided into three groups (n = 6, each) and were treated orally with NaCl 0.9% plus Cremophor® (10 ml/kg, negative control), loperamide (10 mg/kg, positive control), or LM-EtOHAP (125, 250, 500, and 750 mg/kg p.o.). After 30 min of treatment, castor oil was administrated orally (0.01 ml/g) to each animal to induce diarrhea. The animals were separated and placed in individual boxes lined with white paper. Then, the animals were inspected about the number of stools and its consistency for 4 h period, classifying them into solid or liquid and then determined the total number of stools and the number of liquid episodes (Awouters et al., 1978).

The inhibitory effect exerted by LM-EtOHAP was evaluated based on the dose of a drug that produces half of its maximal effect (ED50).

Effect of LM-EtOHAP on Normal and Castor Oil-Induced Intestinal Transit

Male and female mice were divided into three groups (n = 6, each) and after 12 h of fasting period, were treated orally with NaCl 0.9% plus Cremophor® (10 ml/kg, negative control), atropine (2 mg/kg, positive control), or LM-EtOHAP (125, 250, and 500 mg/kg p.o.). Thirty min later, activated charcoal 5% solubilized in carboxymethylcellulose 0.5% (0.01 ml/g) was administered. The animals were euthanized by cervical dislocation 30 min after administration of activated charcoal, the abdominal cavity opened and the small intestine removed. The total length of the small intestine (distance from the pylorus to the ileocecal valve) and the distance traveled by the activated charcoal were measured and compared (Rao et al., 1997). The results were expressed as a percentage of distance traveled by the marker in relation to total length of small intestine.

In other protocols, the same procedures were made, except that castor oil (0.01 ml/g) was administrated orally 30 min before the activated charcoal (Hsu, 1982; Aye-Than et al., 1989).

Effect of LM-EtOHAP Extract on Castor Oil-Induced Intestinal Fluid Accumulation

After 24 h of fasting period, male and female mice (n = 6) were treated orally with NaCl 0.9% (10 ml/kg) plus Cremophor® (negative control), loperamide (10 mg/kg, positive control), or LM–EtOHAP (31.5, 62.5, 125, and 250 µg/ml p.o.). Afterwards, castor oil (2 ml/per animal, p.o.) was administrated and 30 min later the animals were euthanized, the small intestine was dissected, the pylorus to the cecum, the contents expelled, and the volume of the fluid measured (Robert et al., 1976; Di Carlo et al., 1993).

Statistical Analysis

All results were expressed as percentage of the mean ± standard error of the mean (S.E.M.) and statistically analyzed used the Student’s t-test or one-way ANOVA followed by Bonferroni’s post–test, as appropriate, values where significantly different when p < 0.05. The ED50 and EC50 values were calculated by non-linear regression for all experiments (Neubig et al., 2003). All data were analyzed using GraphPad Prism® software version 5.01 (GraphPad Software Inc., San Diego, CA, USA).

Results

Chemical Analysis of LM-EtOHAP

Rosmarinic acid was quantified in the crude ethanolic extract of Leptohyptis macrostachys by high-performance liquid chromatographic-diode array detection. Rosmarinic acid (5.44%) was the most abundant phenolic compound, based on this, could be considered a chemical marker. The value of LOD was 2.31 μg/ml and the value for LOQ was 7.71 μg/ml (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1 HPLC Chromatogram of the crude ethanolic extract of Leptohyptis macrostachys. Chromatographic conditions: Kromasil® 100-C-18 column (250 × 4.6 mm - 5 μm), methanol/water as mobile phase with flow rate of 1 ml/min.

Participation of K+ Channel on the Spasmolytic Activity of LM-EtOHAP on Guinea Pig Ileum

In the relaxation evaluation, LM-EtOHAP relaxant effect (EC50 = 38.9 ± 5.5 μg/ml, n = 5) was attenuated in the presence of 5 mM CsCl (EC50 = 82.1 ± 2.1 μg/ml, n = 5). Contrary, LM-EtOHAP relaxant potency was not altered in the presence of 10–5 M glibenclamide (EC50 = 27.1 ± 2.0 μg/ml, n = 5), 0.3 mM 4–AP (EC50 = 30.0 ± 4.3 μg/ml, n = 5), and 100 nM apamin (EC50 = 23.9 ± 4.5 μg/ml, n = 5). However, the extract relaxant potency was attenuated in the presence of 1 mM TEA+ (EC50 = 60.7 ± 3.0 μg/ml, n = 5) (Table 1).

TABLE 1
www.frontiersin.org

Table 1 Emax (%) and EC50 (μg/ml) values of LM-EtOHAP in both the absence and presence of K+ channel blockers on guinea pig ileum.

Toxicological Evaluation

Investigation of the Hemolytic Effect of LM-EtOHAP in Rat Erythrocytes

LM-EtOHAP (250, 500, and 750 µg/ml, n = 3) did not induce rat erythrocytes lysis, showing no damage to rat erythrocytes membranes at a range of concentrations used (Figure 2).

FIGURE 2
www.frontiersin.org

Figure 2 Hemolytic effect of LM-EtOHAP and triton X-100 (positive control) in rat erythrocytes. Columns and vertical bars represent the mean and S.E.M., respectively (n = 3). One-way ANOVA followed by Bonferroni’s post-test, ***p < 0.01 (control vs. triton X-100).

Evaluation of the Acute Toxicity

LM-EtOHAP (2,500 or 5,000 mg/kg p.o. and 1,000 or 2,000 mg/kg i.p.) did not promote behavioral changes in both male and female mice (n = 6, each) throughout the observation period of 4 h. In addition, the extract also did not induce death in the treated animals during the observation period of 14 days.

Evaluation of Antidiarrheal Activity of LM-EtOHAP in Mice

Effect of LM-EtOHAP on Castor Oil-Induced Diarrhea

LM-EtOHAP (125, 250, 500, and 750 mg/kg p.o., n = 6) inhibited equipotently and in a dose–dependent manner both defecation frequency (ED50 = 248.0 ± 41.0 mg/kg) and number of liquid stools (ED50 = 201.8 ± 21.7 mg/kg). The Emax was achieved at 750 mg/kg, in both parameters, similar to the standard drug loperamide (10 mg/kg) (Figure 3).

FIGURE 3
www.frontiersin.org

Figure 3 Antidiarrheal effect of LM-EtOHAP on castor oil-induced diarrhea in mice. Percentage of total stool numbers (A) and percentage of liquid stools (B). Columns and vertical bars represent the mean and S.E.M., respectively (n = 6). One-way ANOVA followed by Bonferroni’s post–test, *p < 0.05; **p < 0.01 (saline vs. loperamide/LM-EtOHAP).

Effect of LM-EtOHAP on Normal and Castor Oil-Induced Intestinal Transit

LM-EtOHAP (125, 250, and 500 mg/kg p.o., n = 6) did not inhibit the normal intestinal transit. In contrast, atropine (2 mg/kg, p.o., n = 6) decreased the normal intestinal transit from 78.6 ± 2.2% (control) to 58.5 ± 3.8% (Figure 4A).

FIGURE 4
www.frontiersin.org

Figure 4 Effect of LM-EtOHAP on the normal (A) and castor oil-induced (B) intestinal transit in mice. Columns and vertical bars represent the mean and S.E.M., respectively (n = 6). One-way ANOVA followed by Bonferroni’s post-test, **p < 0.01 (saline vs. atropine/LM-EtOHAP).

Moreover, LM-EtOHAP (250, 500, and 750 mg/kg p.o., n = 6) inhibited in a dose-dependent manner the castor oil-induced intestinal propulsion (Emax = 35.4 ± 3.6%, ED50 = 315.3 ± 27.6 mg/kg). In addition, atropine (2 mg/kg p.o., n = 6) decreased the distance traveled by the marker from 86.8 ± 3.1% (control) to 47.4 ± 5.9% (Figure 4B).

Effect of LM-EtOHAP Extract on Castor Oil-Induced Intestinal Fluid Accumulation

LM-EtOHAP (31.5, 62.5, 125, and 250 µg/ml p.o., n = 6) inhibited in a dose-dependent manner the liquid content (Emax = 44.8 ± 5.8%, ED50 = 259.9 ± 65.3 mg/kg). Furthermore, loperamide (10 mg/kg p.o., n = 6) decreased the liquid content from 100.0 ± 0% (control) to 29.4 ± 1.0% (Figure 5).

FIGURE 5
www.frontiersin.org

Figure 5 Effect of LM-EtOHAP on castor oil-induced intestinal fluid accumulation in mice. Columns and vertical bars represent the mean and S.E.M., respectively (n = 6). One-way ANOVA followed by Bonferroni’s post-test, **p < 0.01 (saline vs. loperamide/LM-EtOHAP).

Discussion

In the investigation of this study, we evaluate the role of K+ channels in the spasmolytic action mechanism, toxicological and antidiarrheal activities of LM–EtOHAP, an extract that contains rosmarinic acid as a chemical marker (Figure 1). Moreover, the mechanism underlying its spasmolytic action includes the positive modulation of BKCa leading to smooth muscle relaxation that it is possibly related to its antidiarrheal activity.

Recently, we reported that LM–EtOHAP has selective spasmolytic action on guinea pig ileum, probably, due to the inhibition of Ca2+ influx through voltage-gated calcium channels (CaV) (Souza et al., 2013). Since the contraction of smooth muscle depends on the balance between the increase and decrease of the K+ channels activity, leading to membrane hyperpolarization/repolarization or depolarization, respectively, these channels have been shown to regulate the CaV opening (Thorneloe and Nelson, 2005).

Thereby, we hypothesized that this extract might be inhibiting the Ca2+ influx indirectly via positive modulation of K+ channels. In order to test this hypothesis, the CsCl was used as a pharmacological tool to block K+ channels in a non–selective manner (Cecchi et al., 1987). The relaxant potency of LM–EtOHAP was reduced in the presence of this blocker (Table 1), indicating the role of K+ channels on LM–EtOHAP spasmolytic action. In addition, as the intestinal smooth muscle expresses different subtypes of K+ channels, such as BKca, KATP, Kv, SKca, among others (Vogalis, 2000), we decided to investigate which specific channel was involved in this effect using their selective blockers. The relaxant potency of the extract was reduced in the presence of 1 mM TEA+, but not in the presence of glibenclamide, 4–AP and apamin, suggesting that the activation of BKca promotes relaxation on guinea pig ileum (Table 1).

Alteration of intestinal contractility is a process that characterize intestinal colic, constipation, and diarrhea. Clinically, the pain caused by intestinal spasms are often treated with drugs that induce relaxation of smooth muscles (Sato et al., 2007). In folk medicine, the use of species from Hyptis genus on intestinal disorders treatment is an old practice reported for H. suaveolens, H. martiusii, H. umbrosa, and H. verticillata (Mukherjee et al., 1984; Rojas et al., 1992; Agra et al., 2008). Heretofore, we have shown in vitro that LM–EtOHAP presents spasmolytic activity on intestinal smooth muscle, however no in vivo evidence of an antidiarrheal activity of this extract has been investigated.

Considering that some studies have reported toxicological effects of Hyptis species, such as H. fruticosa (Silva et al., 2006), H. mutabilis (Forgacs et al., 1983), H. martiusii (Caldas et al., 2013), and H. verticillata (Picking et al., 2013), we decide to obtain information regarding the cytotoxic profile and possible acute toxicity of LM–EtOHAP using in vitro and in vivo approach, respectively.

The mechanical stability of the erythrocyte membrane is a good parameter used in cytotoxicity screening, since its structural dynamics favors interactions with drugs that can promote lysis (Sharma and Sharma, 2001). In this study, LM–EtOHAP did not produce damage to rat erythrocyte membranes in the range of concentrations used (Figure 2), suggesting that the extract may not presents toxic effects in other stronger cell types.

Similarly, during the observation period of 4 h neither oral dose nor intraperitoneal dose administration of LM–EtOHAP induce behavioral changes, described as characteristics of toxicity and including parameters of hyperactivity, aggressiveness, sedation, convulsions, among others (Almeida et al., 1999). Therefore, these data demonstrate that the extract did not presents toxic signs on the central nervous system. Moreover, there were no deaths of treated animals during the observation period of 24 h and 14 days, making it impossible to determine the LD50. Thus, these results give us a safety margin to use LM–EtOHAP in the investigation of a possible in vivo antidiarrheal activity.

Currently, international organizations support studies with traditional medicinal practices that seek treatment or prevention of diarrhea (Ventura-Martínez et al., 2011), because this disease is the second leading cause of death in children younger than 5 years old, constituting a public health problem that results in 760,000 children deaths every year (Shafi et al., 2014; WHO, 2019).

Diarrhea is a pathologic condition where the intestinal fluid secretion it is not balanced by absorption, resulting in symptoms as increase of water content, volume, and frequency of stool. In animal models, diarrhea is widely induced using castor oil in order to discover new drugs with potential antidiarrheal activity (Borrelli et al., 2006).

In this study, LM–EtOHAP inhibited castor oil-induced diarrhea regarding both defecation frequency and number of liquid stools (Figure 3), suggesting that the extract has active constituents with antidiarrheal activity. These substances may change the bowel motility inhibiting the intestinal transit or increasing water and electrolyte absorption in the gastrointestinal tract (Field and Semrad, 1993). Hence, we investigated if changes in the intestinal transit and/or fluid accumulation are related to the antidiarrheal activity of LM–EtOHAP.

Interestingly, the extract did not inhibit the normal intestinal transit, however, atropine, used as positive control, decrease the distance traveled by the activated charcoal (Figure 4A). Despite this, LM–EtOHAP inhibited in a dose-dependent manner the castor oil-induced intestinal transit and atropine also decrease the distance traveled by the marker (Figure 4B), suggesting that the antidiarrheal effect of the extract involves alterations in the intestinal motility only in pathologic condition.

In diarrhea, there is a pronounced stimulation of cells secretion that becomes greater than the amount capable of being resorbed (Menezes et al., 1994). In castor oil-induced intestinal fluid accumulation model is developed an electrolyte hypersecretory response (Mascolo et al., 1993). Thus, using this protocol we showed that the extract inhibited, in a dose-dependent manner, the intestinal fluid accumulation (Figure 5), suggesting that LM–EtOHAP antidiarrheal effect also involves decrease in intestinal secretion. This action is desirable since the main common manifestation of different types of diarrhea is the dehydration and, in many cases, intestinal transit inhibition is not desired because it can delay or prevent the elimination of potential pathogens (Gurgel et al., 2001).

In conclusion, the spasmolytic action of LM–EtOHAP, on guinea pig ileum involves the positive modulation of BKca. In addition, the extract does not have cytotoxic effect or systemic toxicity in mice. Interestingly, it is now established that LM–EtOHAP has an antidiarrheal effect, as it inhibits both intestinal motility and secretion. Complementary studies are necessary to better elucidate the action mechanism of this potential antidiarrheal agent. Additionally, it is relevant to conduct studies with rosmarinic acid to verify whether the observed effects are due to its spasmolytic and antidiarrheal potential.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.

Ethics Statement

The animal study was reviewed and approved by Ethics Committee in Research (CEP) of UFAL, certificate no. 006775/2011-09, and the Ethics Committee on Animal Use (CEPA/UFPB), certificate no. 0506/05.

Author Contributions

IS is the author who mainly contributed to this research, performing literature search, pharmacological experiments, analysis of the data, and writing the manuscript. MV, AS, and PS were involved in acquisition, interpretation, and analysis of in vivo pharmacological experiments. CV, DA, VC, JT, and MS performed the phytochemical experiments. HP was involved in toxicological experiments. BS and FC were involved in design, interpretation of the data, and review of the manuscript. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors thank CAPES and CNPq, for financial support; UFAL, UFPB, and PPgPNSB for experimental support; and José Crispim Duarte for providing technical assistance.

Abbreviations

HPLC–DAD, high-performance liquid chromatographic-diode array detection; LM-EtOHAP, crude ethanolic extract obtained from the aerial parts of Leptohyptis macrostachys; BKCa, selective big–conductance K+ channels blocker; PPgPNSB, Programa de Pós–graduação em Produtos Naturais e Sintéticos Bioativos; CCS, Centro de Ciências da Saúde; UFPB, Universidade Federal da Paraíba; TEA+, tetraethylammonium chloride; 4–AP, 4–aminopyridine; CsCl, cesium chloride; KATP, selective ATP sensitive K+ channels blocker; KV, selective voltage activated K+ channels blocker; SKCa, selective small–conductance K+ channels blocker; BKCa, selective big–conductance K+ channels blocker; EC50, molar concentration of a substance that produces half of its maximum effect; Emax, maximum effect; LD50, the lethal dose of extract to 50% of treated animals; ED50, dose of a drug that produces half of its maximal effect; S.E.M., mean ± standard error of the mean.

References

Agra, M. F., Rocha, E. A., Formiga, S. C., Locatelli, E. (2008). Survey of medicinal plants used in the region Northeast of Brazil. Rev. Bras. Farmacogn. 18, 472–508. doi: 10.1590/S0102-695X2008000300023

CrossRef Full Text | Google Scholar

Almeida, R. N., Falcão, A. C. G. M., Diniz, R. S. T., Quintanas-Júnior, L. J., Polari, R. M., Barbosa-Filho, J. M., et al. (1999). Metodologia para avaliação de plantas com atividade no Sistema Nervoso Central e alguns dados experimentais. Rev. Bras. Farmacogn. 80, 72–76.

Google Scholar

Almtorp, G. T., Hazell, A. C., Torssell, K. B. G. (1991). A lignan and pyrone and other constituents from Hyptis capitata. Phytochemistry 30, 2753–2756. doi: 10.1016/0031-9422(91)85137-O

CrossRef Full Text | Google Scholar

Andrade, T. A., Freitas, T. S., Araújo, F. O., Menezes, P. P., Dória, G. A. A., Rabelo, A. S., et al. (2017). Physico-chemical characterization and antibacterial activity of inclusion complexes of Hyptis martiusii Benth essential oil in β-cyclodextrin. Biomed. Pharmacother. 89, 201–207. doi: 10.1016/j.biopha.2017.01.158

PubMed Abstract | CrossRef Full Text | Google Scholar

Anjos, K. S., Araújo-Filho, H. G., Duarte, M. C., Costa, V. C., Tavares, J. F., Silva, M. S., et al. (2017). HPLC-DAD analysis, antinociceptive and anti-inflammatory properties of the ethanolic extract of Hyptis umbrosa in mice. EXCLI J. 16, 14. doi: 10.17179/excli2016-698

PubMed Abstract | CrossRef Full Text | Google Scholar

Attah, F. A., O’Brien, M., Koehbach, J., Sonibare, A. M., Moody, O. J., Smith, J. T., et al. (2012). Uterine contractility of plants used to facilitate childbirth in Nigerian ethnomedicine. J. Ethnopharmacol. 143, 377–382. doi: 10.1016/j.jep.2012.06.042

PubMed Abstract | CrossRef Full Text | Google Scholar

Awouters, F., Neimegeers, C. J. E., Lenaert, F. M., Jassen, L. (1978). Delay of castor oil diarrhoeal in rats; A new way to evaluate inhibitors of prostaglandin’s biosynthesis. J. Pharm. Pharmacol. 30, 41–45. doi: 10.1111/j.2042-7158.1978.tb13150.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Aye-Than, J. H., Kukami, W., Tha, S. J. (1989). Antidiarrhoeal efficacy of some Burmese indigenous drug formulations in experimental diarrhoea test models. J. Crude Drug Res. 27, 195–200. doi: 10.3109/13880208909116903

CrossRef Full Text | Google Scholar

Barbosa, A. G., Oliveira, C. D., Lacerda-Neto, L. J., Vidal, C. S., Saraiva, R. D. A., Costa, J. G., et al. (2017). Evaluation of chemical composition and antiedematogenic activity of the essential oil of Hyptis martiusii Benth. Saudi J. Biol. Sci. 24 (2), 355–361. doi: 10.1016/j.sjbs.2015.10.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Borrelli, F., Capasso, F., Capasso, R., Ascione, V., Aviello, G., Longo, L., et al. (2006). Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhea without constipation. Br. J. Pharmacol. 148, 553–560. doi: 10.1038/sj.bjp.0706740

PubMed Abstract | CrossRef Full Text | Google Scholar

Caldas, G. F. R., Araújo, A. V., Albuquerque, G. S., Silva-Neto, J. C., Costa-Silva, J. H., Menezes, I. R. A., et al. (2013). Repeated-Doses Toxicity Study of the Essential Oil of Hyptis martiusii Benth. (Lamiaceae) in Swiss Mice. Evid. Based Complement. Alternat. Med. 2013, 1–11. doi: 10.1155/2013/856168

CrossRef Full Text | Google Scholar

Cecchi, X., Wolff, D., Alvarez, O., Latorre, R. (1987). Mechanisms of Cs+ blockade in a Ca2+–activated K+ channel from smooth muscle. Biophys. J. 52, 707716. doi: 10.1016/S0006-3495(87)83265-4

CrossRef Full Text | Google Scholar

Costa, V. C. O., Tavares, J. F., Silva, A. B., Duarte, M. C., Agra, M. F., Barbosa-Filho, J. M., et al. (2014). Hyptenolide, a new α-pyrone with spasmolytic activity from Hyptis macrostachys. Phytochem. Lett. 8, 32–37. doi: 10.1016/j.phytol.2014.01.009

CrossRef Full Text | Google Scholar

Daniel, E. E., Kwan, C. Y., Janssen, L. (2001). Pharmacological techniques for the in vitro study of intestinal smooth muscle. J. Pharmacol. Toxicol. 45, 141–158. doi: 10.1016/S1056-8719(01)00131-9

CrossRef Full Text | Google Scholar

Di Carlo, G., Autore, G., Izzo, A. A., Maiolino, P., Mascolo, N., Viola, P., et al. (1993). Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationships. J. Pharm. Pharmacol. 45, 1054–1059. doi: 10.1111/j.2042-7158.1993.tb07180.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Field, M., Semrad, C. E. (1993). Toxigenic diarrheas, congenital diarrheas, and cystic fibrosis: disorders of intestinal ion transport. Annu. Rev. Physiol. 55, 631–655. doi: 10.1146/annurev.ph.55.030193.003215

PubMed Abstract | CrossRef Full Text | Google Scholar

Figueiredo, F.R.S.D.N., Monteiro, Å., Menezes, I. R. A., Santos Sales, V., Nascimento, E. P., Souza Rodrigues, C. K., et al. (2019). Effects of the Hyptis martiusii Benth. leaf essential oil and 1, 8-cineole (eucalyptol) on the central nervous system of mice. Food Chem. Toxicol. 133, 110802. doi: 10.1016/j.fct.2019.110802

PubMed Abstract | CrossRef Full Text | Google Scholar

Forgacs, P., Jacquemin, H., Moretti, C., Provost, J., Touche, A. (1983). Phytochemical and biological activity studies on 18 plants from French Guyana. Plant Med. Phytother. 17, 2232.

Google Scholar

Gurgel, L. A., Silva, R. M., Santos, F. A., Martins, T. O., Mattos, P. O., Rao, V. S. N. (2001). Studies on the antidiarrhoeal effects of dragons blood from Croton urucurana. Phytother. Res. 15, 319–322. doi: 10.1002/ptr.728

PubMed Abstract | CrossRef Full Text | Google Scholar

Hsu, W. H. (1982). Xylazine induced delay of small intestinal transit in mice. Eur. J. Pharmacol. 83, 55–60. doi: 10.1016/0014-2999(82)90285-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Ishii, T. M., Maylie, J., Adelman, J. P. (1997). Determinants of apamin and d–tubocurarine block in SK potassium channels. J. Biol. Chem. 272, 2319523200. doi: 10.1074/jbc.272.37.23195

CrossRef Full Text | Google Scholar

Knot, H. T., Brayden, E. J., Nelson, M. T., Bárány, M. (1996). “Calcium channels and potassium channels,” in Biochemistry of smooth muscle contraction (San Diego: Academic Press), 203219.

Google Scholar

Mascolo, N., Izzo, A. A., Barbato, F., Capasso, F. (1993). Inhibiton of nitric oxide synthetase prevent castor-oil induced diarrhoea in the rat. Br. J. Pharmacol. 108, 861–864. doi: 10.1111/j.1476-5381.1993.tb13478.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Menezes, M. A. S., Viana, G. S. B., Vietla, S. N. R., Corrêa, R. A., Feijó, S. G. F. (1994). “Estudo farmacológico,” in Aroeira do sertão (Myracrodruon urundeuva Fr. All.), vol. 187 . Eds. Viana, G. S. B., Matos, F. J. A., Bandeira, M. A. M., Rao, V. S. N. (Fortaleza: UFC), 83–174.

Google Scholar

Mukherjee, K. S., Mukherjee, R. K., Ghosh, P. K. (1984). Chemistry of Hyptis suaveolens: a pentacyclic triterpene. J. Nat. Prod. 47, 377–378. doi: 10.1021/np50032a025

CrossRef Full Text | Google Scholar

Neubig, R. R., Spedding, M., Kenakin, T., Christopoulos, A. (2003). International union of pharmacology committee on receptor nomenclature and drug classification. VIII. Update on terms and symbols in quantitative pharmacology. Pharmacol. Rev. 55, 597–606. doi: 10.1124/pr.55.4.4

PubMed Abstract | CrossRef Full Text | Google Scholar

Otimenyin, S. O., Uzochukwu, D. C. (2010). Spasmolytic and anti-diarrhea effects of the bark if Erythrina senegalensis and root of Kigelia africana. Asian J. Pharm. Clin. Res. 3, 11–14.

Google Scholar

Picking, D., Delgoda, R., Boulogne, I., Mitchell, S. (2013). Hyptis verticillata Jacq: A review of its traditional uses, phytochemistry, pharmacology and toxicology. J. Ethnopharmacol. 147, 16–41. doi: 10.1016/j.jep.2013.01.039

PubMed Abstract | CrossRef Full Text | Google Scholar

Raja, R. R. (2012). Medicinally Potential Plants of Labiatae (Lamiaceae) Family: An Overview. J. Med. Plants Res. 6, 203–213. doi: 10.3923/rjmp.2012.203.213

CrossRef Full Text | Google Scholar

Rangel, M., Malpezzi, E. L. A., Susini, S. M. M., Freitas, J. C. (1997). Hemolytic activity in extracts of the diatom Nitzschia. Toxicon 35, 305–309. doi: 10.1016/S0041-0101(96)00148-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Rao, V. S. N., Santos, F. A., Sobreira, T. T., Souza, M. F., Melo, C. L., Silveira, E. R. (1997). Investigations on the gastroprotective and antidiarrhoeal properties of ternatin, a tetramethoxyflavone from Egletes viscose. Planta Med. 63, 146–149. doi: 10.1055/s-2006-957632

PubMed Abstract | CrossRef Full Text | Google Scholar

Robert, A., Nezarmis, J. E., Lancaster, C., Henchar, A. I., Kleppre, M. S. (1976). Enteropooling Assay: A test for diarrhea produced by prostaglandins. Prostaglandins 11, 809–814. doi: 10.1016/0090-6980(76)90189-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Robertson, B. E., Nelson, M. T. (1994). Aminopyridine inhibition and voltage dependence of K+ currents in smooth muscle cells from cerebral arteries. Am. J. Physiol. 267, 15891597. doi: 10.1152/ajpcell.1994.267.6.C1589

CrossRef Full Text | Google Scholar

Rocha, J. E., Coutinho, H. D. M., Saraiva, C. R. N., Santos, A. T. L., Machado, A. J. T., Júnior, J. T. C., et al. (2019). HPLC-DAD analysis and potentiation of the antifungal effect of fluconazole against Candida strains by natural products from Hyptis martiusii Benth (Lamiaceae). Asian Pac. J. Trop. Biomed. 9, 123–128. doi: 10.4103/2221-1691.254606

CrossRef Full Text | Google Scholar

Rojas, A., Hernandez, L., Pereda-Miranda, R., Mata, R. (1992). Screening for antimicrobial activity of crude drug extracts and pure natural products from Mexican medicinal plants. J. Ethnopharmacol. 35, 275283. doi: 10.1016/0378-8741(92)90025-M

CrossRef Full Text | Google Scholar

Sato, Y., He, J. X., Nagai, H., Tani, T., Akao, T. (2007). Isoliquiritigenin, one of the antispasmodic principles of Glycyrrhiza ularensis roots, acts in the lower part of intestine. Biol. Pharm. Bull. 30, 145–149. doi: 10.1248/bpb.30.145

PubMed Abstract | CrossRef Full Text | Google Scholar

Schiller, L. R. (2017). Antidiarrheal Drug Therapy. Curr. Gastroenterol. Rep. 19, 18. doi: 10.1007/s11894-017-0557-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Shafi, A., Farooq, U., Akram, K., Jaskani, M., Siddique, F., Tanveer, A. (2014). Antidiarrheal effect of food fermented by various strains of Lactobacillus. Compr. Rev. Food Sci. F. 13, 229–239. doi: 10.1111/1541-4337.12056

CrossRef Full Text | Google Scholar

Shaikat, M. Z. H., Hossai, M. T., Azam, M. G. (2012). Phytochemical Screening and Antidiarrhoeal Activity of Hyptis suaveolens. Int. J. Appl. Res. Nat. Prod. 2, 1–4.

Google Scholar

Sharma, P., Sharma, J. D. (2001). In vitro hemolysis of human erythrocytes by plant extracts with antiplasmodial activity. J. Ethnophamacol. 74, 239–243. doi: 10.1016/S0378-8741(00)00370-6

CrossRef Full Text | Google Scholar

Silva, A. B. L., Dias, K. S., Marques, M. S., Menezes, I. A. C., Santos, T. C., Mello, I. C. M., et al. (2006). Evaluation of the analgesic effect and acute toxicity of the aqueous extract of Hyptis fruticosa (Salmz. Ex Benth.). Braz. J. Pharmacog. 16, 475–479. doi: 10.1590/S0102-695X2006000400006

CrossRef Full Text | Google Scholar

Sousa, V. R., Couri, M. S. (2013). Calycomyza hyptidis Spencer (Diptera, Agromyzidae): descriptions, redescriptions and first record in Ocimum basilicum (Lamiaceae) in Brazil. Rev. Bras. Entomol. 57, 209–212. doi: 10.1590/S0085-56262013005000007

CrossRef Full Text | Google Scholar

Souza, I. L. L., Oliveira, G. A., Travassos, R. A., Vasconcelos, L. H. C., Correia, A. C. C., Martins, I. R. R., et al. (2013). Spasmolytic activity of Hyptis macrostachys Benth. (Lamiaceae). J. Med. Plants Res. 7, 2436–2443. doi: 10.5897/JMPR2013.4484

CrossRef Full Text | Google Scholar

Stevens, P. F.Angiosperm Phylogeny Website. Version 12. Available from: http://www.mobot.org (Accessed 02 december 2018).

Google Scholar

Sun, Y. D., Benishin, C. G. (1994). K+ channel openers relax longitudinal muscle of guinea–pig ileum. Eur. J. Pharmacol. 271, 453459. doi: 10.1016/0014-2999(94)90806-0

CrossRef Full Text | Google Scholar

Thorneloe, K. S., Nelson, M. T. (2005). Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can. J. Physiol. Pharmacol. 83, 215–242. doi: 10.1139/y05-016

PubMed Abstract | CrossRef Full Text | Google Scholar

Ventura-Martínez, R., Rivero-Osorno, O., Gómez, C., González-Trujano, M. E. (2011). Spasmolytic activity of Rosmarinus officinalis L. involves calcium channels in the guinea pig ileum. J. Ethnopharmacol. 137, 1528–1532. doi: 10.1016/j.jep.2011.08.047

PubMed Abstract | CrossRef Full Text | Google Scholar

Vogalis, F. (2000). Potassium channels in gastrointestinal smooth muscle. J. Auton. Pharmacol. 20, 207–219. doi: 10.1046/j.1365-2680.2000.00183.x

PubMed Abstract | CrossRef Full Text | Google Scholar

World Health OrganizationWorld Health Organization Diarrhea Guidelines. Available from: http://www.who.int/topics/diarrhoea/en (Accessed 02 jan 2019).

Google Scholar

Keywords: Leptohyptis macrostachys, Lamiaceae, spasmolytic activity, antidiarrheal activity, potassium channel

Citation: de Souza ILL, de Vasconcelos MA, da Silva ADS, Silva PCB, Veloso CAG, de Araújo DIAF, Costa VCdO, Pessôa HLF, Tavares JF, da Silva MS, da Silva BA and Cavalcante FdA (2020) Toxicological and Pharmacological Activities of Leptohyptis macrostachys (Benth.) Harley and J.F.B.Pastore (Lamiaceae) on Intestinal Smooth Muscle. Front. Pharmacol. 11:1042. doi: 10.3389/fphar.2020.01042

Received: 18 May 2020; Accepted: 26 June 2020;
Published: 10 July 2020.

Edited by:

Raffaele Capasso, University of Naples Federico II, Italy

Reviewed by:

Irwin Rose Alencar de Menezes, Regional University of Cariri, Brazil
Workineh Shibeshi, Addis Ababa University, Ethiopia
Rosa Ventura-Martinez, National Autonomous University of Mexico, Mexico

Copyright © 2020 de Souza, de Vasconcelos, da Silva, Silva, Veloso, de Araújo, Costa, Pessôa, Tavares, da Silva, da Silva and Cavalcante. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Fabiana de Andrade Cavalcante, fabianacavalcante@ltf.ufpb.br

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.